Fig. 2From: Peptide receptor radionuclide therapy in patients with medullary thyroid carcinoma: predictors and pitfallsProgression free survival. Abbreviations: PD, progressive disease, SD, stable disease. Footnote: SD censored patient is still in follow-up with stable disease 1.6 years after start of treatmentBack to article page